In the last ten years, the Swiss biotech industry has grown by over 50% and has established itself as one of the leading biotech hubs. The confidence in the added value and innovative strength of this industry remains unbroken, as evidenced by record levels of investment and sustained growth in all areas. The full development pipeline of biotech companies and the quality of their patents ensure that Swiss biotechnology will continue to play a strong, competitive role on the world market in the long term.
Read more in the German biotechnology anniversary issue of the "Plattform Life Sciences".